Literature DB >> 2155903

Thrombocytosis and thrombocythemia.

A J Mitus1, A I Schafer.   

Abstract

Elevated platelet counts may be encountered as a reactive phenomenon secondary to a variety of systemic conditions (thrombocytosis) or may represent a primary disorder of the bone marrow (thrombocythemia). The diagnosis of essential thrombocythemia is difficult and relies on exclusion of other myeloproliferative states and nonhematologic illnesses associated with increased platelet number. The paradoxic clinical complications of hemorrhage and thrombosis, the presence of splenomegaly, and the finding of various qualitative platelet abnormalities point to existence of the neoplastic disorder. Although treatment of the symptomatic patient with platelet lowering agents or antiplatelet drugs may be indicated and effective, the role of therapy in the asymptomatic individual remains highly controversial.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155903

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  9 in total

Review 1.  Primary thrombocythemia: diagnosis, clinical manifestations and management.

Authors:  P J van Genderen; J J Michiels
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

Review 2.  Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review.

Authors:  Beste Ozben; Ahmet Ekmekci; Zehra Bugra; Sabahattin Umman; Mehmet Meric
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

Review 3.  The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

Authors:  Prajwal Boddu; Lorenzo Falchi; Chitra Hosing; Kate Newberry; Prithviraj Bose; Srdan Verstovsek
Journal:  Leuk Res       Date:  2017-03-22       Impact factor: 3.156

4.  Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia.

Authors:  M R Howard; S Ashwell; L R Bond; I Holbrook
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

5.  Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma.

Authors:  Dae Sung Cho; Se Joong Kim; Soo Hyung Lee; Hyun Soo Ahn; Young Soo Kim; Sun Il Kim
Journal:  Korean J Urol       Date:  2011-02-21

6.  Aortic thrombus in a patient with myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a case report.

Authors:  Hidesuke Yamamoto; Haruaki Nishimaki; Norikazu Imai; Masakazu Nitta; Osami Daimaru
Journal:  J Med Case Rep       Date:  2010-07-21

7.  Jak-2 mutation frequency in patients with thrombocytosis.

Authors:  Osman Yokus; Habip Gedik
Journal:  Caspian J Intern Med       Date:  2018

8.  Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia.

Authors:  Emin Alioglu; Nurullah Tuzun; Fahri Sahin; Buket Kosova; Serkan Saygi; Istemihan Tengiz; Ugur Turk; Nazan Ozsan; Ertugrul Ercan
Journal:  Thromb J       Date:  2009-02-20

9.  Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?

Authors:  Tanja Belčič Mikič; Bor Vratanar; Tadej Pajič; Saša Anžej Doma; Nataša Debeljak; Irena Preložnik Zupan; Matjaž Sever; Samo Zver
Journal:  J Clin Med       Date:  2021-12-11       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.